Evidence map›Paper›PMID 23342031›Full record

ArticlePloS one2013

The V protein of Tioman virus is incapable of blocking type I interferon signaling in human cells.

Grégory Caignard, Marianne Lucas-Hourani, Kevin P Dhondt, Jean-Louis Labernardière, Thierry Petit, Yves Jacob, Branka Horvat, Frédéric Tangy, Pierre-Olivier Vidalain

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Zoonotic and reverse zoonotic transmission of viruses between humans and pigs.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2021
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. MicroRNA Expression Profiling in Behçet's Disease.Journal of immunology research · 2018
    Article
  11. Article
  12. Immune Response toJournal of immunology research · 2018
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Grégory CaignardUnité de Génomique Virale et Vaccination, Centre National de la Recherche Scientifique, URA-3015, Virology Department, Institut Pasteur, Paris, France.
Marianne Lucas-Hourani
Kevin P Dhondt
Jean-Louis Labernardière
Thierry Petit
Yves Jacob
Branka Horvat
Frédéric Tangy
Pierre-Olivier Vidalain
Centre National de la Recherche Scientifique · FRInserm · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The capacity of a virus to cross species barriers is determined by the development of bona fide interactions with cellular components of new hosts, and in particular its ability to block IFN-α/β antiviral signaling. Tioman virus (TioV), a close relative of mumps virus (MuV), has been isolated in giant fruit bats in Southeast Asia. Nipah and Hendra viruses, which are present in the same bat colonies, are highly pathogenic in human. Despite serological evidences of close contacts between TioV and human populations, whether TioV is associated to some human pathology remains undetermined. Here we show that in contrast to the V protein of MuV, the V protein of TioV (TioV-V) hardly interacts with human STAT2, does not degrade STAT1, and cannot block IFN-α/β signaling in human cells. In contrast, TioV-V properly binds to human STAT3 and MDA5, and thus interferes with IL-6 signaling and IFN-β promoter induction in human cells. Because STAT2 binding was previously identified as a host restriction factor for some Paramyxoviridae, we established STAT2 sequence from giant fruit bats, and binding to TioV-V was tested. Surprisingly, TioV-V interaction with STAT2 from giant fruit bats is also extremely weak and barely detectable. Altogether, our observations question the capacity of TioV to appropriately control IFN-α/β signaling in both human and giant fruit bats that are considered as its natural host.

Indexed as

Signal TransductionAnimalsChiropteraDEAD-box RNA HelicasesHEK293 CellsHumansInterferon-Induced Helicase, IFIH1Interferon Type IMumps virusRNA HelicasesRubulavirusSTAT3 Transcription FactorViral ProteinsDEAD-box RNA HelicasesDHX58 protein, humanIFIH1 protein, humanInterferon-Induced Helicase, IFIH1Interferon Type IRNA HelicasesSTAT3 Transcription FactorViral Proteins

Identifiers

PMID23342031
PMCPMC3544715
OpenAlexW2041290472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.